Exploiting synthetic lethal interactions for targeted cancer therapy by Reinhardt, H. Christian, Jiang, Hai, Hemann, Michael, Yaffe, Michael B

Get full text
Get full text

A Reversible Gene-Targeting Strategy Identifies Synthetic Lethal Interactions between MK2 and p53 in the DNA Damage Response In Vivo by Reinhardt, H. Christian, Kim, Jacob S., Ruf, Daniela M., Mitra, Tanya, Couvillon, Anthony D., Yaffe, Michael B., Cannell, Ian Gordon, Reinhardt, H. Christian, Kim, Jacob S., Ruf, Daniela M., Morandell, Sandra M., Jacks, Tyler E, Yaffe, Michael B

Get full text
Get full text
Get full text

DNA Damage Activates a Spatially Distinct Late Cytoplasmic Cell-Cycle Checkpoint Network Controlled by MK2-Mediated RNA Stabilization by Reinhardt, H. Christian, Hasskamp, Pia, Schmedding, Ingolf, Morandell, Sandra, van Vugt, Marcel A.T.M., Wang, XiaoZhe, Linding, Rune, Ong, Shao-En, Weaver, David, Carr, Steven A., Yaffe, Michael B

Get full text
Get full text

Enhancing chemotherapy response through augmented synthetic lethality by co-targeting nucleotide excision repair and cell-cycle checkpoints by Kong, Yi Wen, Dreaden, Erik C, Morandell, Sandra, Zhou, Wen, Dhara, Sanjeev S, Sriram, Ganapathy, Lam, Fred C, Patterson, Jesse C, Quadir, Mohiuddin, Dinh, Anh, Shopsowitz, Kevin E, Varmeh, Shohreh, Yilmaz, Ömer H, Lippard, Stephen J, Reinhardt, H Christian, Hemann, Michael T, Hammond, Paula T, Yaffe, Michael B

Get full text